Source: Annual Congress 2006 - Pathogenic aspects of lung injury, destruction and repair
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Yamaguchi, E. C. Gabazza, T. Takagi, T. Maruyama, H. Nakahara, Y. Nishii, H. Fujimoto, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Japan). Role of NF-κB p50 in bleomycin induced pulmonary fibrosis. Eur Respir J 2006; 28: Suppl. 50, 1165

Member's Comments

No comment yet.

Related content which might interest you: Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Effect of simvastatin on bleomycin induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Inhibition of pulmonary collagen-I, III and fibrotic cytokins in bleomycin induced pulmonary fibrosis by okam J201 Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Danshenextract salt Inhibits bleomycin-induced experimental pulmonary fibrosis Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Neutrophil extracellular traps contribute to pulmonary fibrosis induced by bleomycin Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004 Olodaterol attenuates bleomycin induced lung fibrosis in mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Interdependence of HIF1alpha /TGFbeta1 activity in induction of pulmonary fibrosis Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-beta/Smad signaling Source: International Congress 2014 – ILDs 4 Year: 2014 Effect of NF-?B inhibitor IMD-1041 on BLM-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages Source: Eur Respir J, 51 (3) 1702120; 10.1183/13993003.02120-2017 Year: 2018 Effects of rapamycin on bleomycin induced pulmonary fibrosis in rats and analysis of the underlying mechanism Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007 Role of the inflammasome in idiopathic pulmonary fibrosis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2 Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Bleomycin and paraquat-mediated pulmonary fibrosis is IL-17 independent Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Expression of TGF-β and TGFβ receptors in bleomycin-induced pulmonary fibrosis of rats Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Role of Extracellular HSP27 in pulmonary fibrosis Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015